Page 2 - Aurinia Year End News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aurinia year end. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aurinia Year End Today - Breaking & Trending Today

LUPKYNIS® (voclosporin) Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone

Aurinia Pharmaceuticals Inc. today announced the results of a post-hoc, pooled analysis of the Phase 2 AURA-LV and Phase 3 AURORA 1 studies, which found that LUPKYNIS® with mycophenolate. | June 1, 2023 ....

United States , Emily Littlejohn , Greg Keenan , Aurinia Pharmaceuticals , European Congress , Aurinia Pharmaceuticals Inc , Cleveland Clinic Main Campus , Immunologic Disease , Chief Medical Officer , Red Cell Aplasia , Drug Interactions , Moderate Hepatic Impairment , Prescribing Information , Boxed Warning , Medication Guide , Aurinia Pharmaceuticals Inc Stock Exchange , Press Release , Ith Auph Ca05156v1022 ,

Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees

Aurinia Pharmaceuticals Inc. today announced the filing of a registration statement on Form S-8 with the United States Securities and Exchange Commission .

Under U.S. federal securities laws,. | May 26, 2023 ....

United States , Aurinia Pharmaceuticals Inc , Aurinia Pharmaceuticals , Exchange Commission , United States Securities , Securities Act , Nasdaq Listing Rule , Aurinia Pharmaceuticals Inc Stock Exchange , Press Release , Ecurities Auph Ca05156v1022 ,

Aurinia Announces 2023 Annual General Meeting Results

Aurinia Pharmaceuticals Inc. today announced voting results for its annual general meeting of shareholders held on May 17, 2023.

Shareholders re-elected six of eight incumbent directors to the. | May 17, 2023 ....

George Milne , Hector Mackay Dunn , Peter Greenleaf , Joseph Jay Hagan , Company Majority Voting , Aurinia Pharmaceuticals Inc , Aurinia Governance Nomination Committee , Aurinia Pharmaceuticals , Majority Voting , Aurinia Pharmaceuticals Inc Stock Exchange , Press Release , O Auph Ca05156v1022 ,

Aurinia Pharmaceuticals Inc.: Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results

$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year Increases 2023 revenue guidance range to $135 $155 million from net product ....

United Kingdom , United States , Peter Greenleaf , Toni Braxton , Aurinia Pharmaceuticals Inc , Company Quarterly Report On Form , Aurinia Pharmaceuticals , United Kingdom National Institute For Health , Exchange Commission Electronic Document Gathering , Company Annual Report On Form , Chief Executive Officer , Grammy Award , Get Uncomfortable , National Institute , Care Excellence , Three Months Ended March , Quarterly Report , Annual Report , Canadian Securities Administrator System , Electronic Document Analysis , Exchange Commission , Electronic Document Gathering , Retrieval System ,

Aurinia: Q1 Earnings Snapshot | MarketScreener

VICTORIA, British Columbia — VICTORIA, British Columbia — Aurinia Pharmaceuticals Inc. on Thursday reported a loss of $26.2 million in its first quarter.
The Victoria, British. | May 4, 2023 ....

United Kingdom , Aurinia Pharmaceuticals Inc , Zacks Investment Research , British Columbia , British Columbia Based , Investment Research , Automated Insights , Aurinia Pharmaceuticals Inc Stock Exchange , Press Release , He Auph Ca05156v1022 ,